Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
FEBS Lett ; 597(16): 2119-2132, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-37278160

RESUMEN

Mycobacterium tuberculosis (MTB) is the etiologic agent of tuberculosis (TB), an ancient disease which causes 1.5 million deaths worldwide. Dihydroorotate dehydrogenase (DHODH) is a key enzyme of the MTB de novo pyrimidine biosynthesis pathway, and it is essential for MTB growth in vitro, hence representing a promising drug target. We present: (i) the biochemical characterization of the full-length MTB DHODH, including the analysis of the kinetic parameters, and (ii) the previously unreleased crystal structure of the protein that allowed us to rationally screen our in-house chemical library and identify the first selective inhibitor of mycobacterial DHODH. The inhibitor has fluorescence properties, potentially instrumental to in cellulo imaging studies, and exhibits an IC50 value of 43 µm, paving the way to hit-to-lead process.


Asunto(s)
Mycobacterium tuberculosis , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH , Tuberculosis , Humanos , Dihidroorotato Deshidrogenasa , Mycobacterium tuberculosis/metabolismo , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH/química , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH/metabolismo , Sistemas de Liberación de Medicamentos , Inhibidores Enzimáticos/farmacología , Inhibidores Enzimáticos/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA